These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 33640465)

  • 1. VEGFR1 signaling in retinal angiogenesis and microinflammation.
    Uemura A; Fruttiger M; D'Amore PA; De Falco S; Joussen AM; Sennlaub F; Brunck LR; Johnson KT; Lambrou GN; Rittenhouse KD; Langmann T
    Prog Retin Eye Res; 2021 Sep; 84():100954. PubMed ID: 33640465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
    Mac Gabhann F; Popel AS
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
    Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture.
    Jiao W; Ji JF; Xu W; Bu W; Zheng Y; Ma A; Zhao B; Fan Q
    Sci Rep; 2019 Oct; 9(1):15339. PubMed ID: 31653890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.
    Cao R; Xue Y; Hedlund EM; Zhong Z; Tritsaris K; Tondelli B; Lucchini F; Zhu Z; Dissing S; Cao Y
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):856-61. PubMed ID: 20080765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes.
    Tanaka K; Watanabe M; Tanigaki S; Iwashita M; Kobayashi Y
    Placenta; 2018 Dec; 74():20-27. PubMed ID: 30591201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases.
    Shibuya M
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):135-44. PubMed ID: 25772179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.
    Huang H; Parlier R; Shen JK; Lutty GA; Vinores SA
    PLoS One; 2013; 8(8):e71808. PubMed ID: 23977149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
    Shih SC; Ju M; Liu N; Smith LE
    J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases.
    Van Bergen T; Etienne I; Cunningham F; Moons L; Schlingemann RO; Feyen JHM; Stitt AW
    Prog Retin Eye Res; 2019 Mar; 69():116-136. PubMed ID: 30385175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
    Szabo E; Schneider H; Seystahl K; Rushing EJ; Herting F; Weidner KM; Weller M
    Neuro Oncol; 2016 Sep; 18(9):1242-52. PubMed ID: 27009237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition.
    Huang H; He J; Johnson D; Wei Y; Liu Y; Wang S; Lutty GA; Duh EJ; Semba RD
    Diabetes; 2015 Jan; 64(1):200-12. PubMed ID: 25187372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
    Shibuya M
    J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative modulation of angiogenesis by VEGFR1 ligands.
    Cao Y
    Sci Signal; 2009 Feb; 2(59):re1. PubMed ID: 19244214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.
    Huang H; Shen J; Vinores SA
    PLoS One; 2011; 6(6):e21411. PubMed ID: 21731737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGFR1 and VEGFR2 in Alzheimer's Disease.
    Harris R; Miners JS; Allen S; Love S
    J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
    Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
    Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
    Balser C; Wolf A; Herb M; Langmann T
    J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.